Acerta Pharma B.V.
THE NETHERLANDS CORPORATE OFFICE,
ACERTA PHARMA BV
Kloosterstraat 9
5349 AB Oss
The Netherlands
Main Phone +31 412-700574
info-Netherlands@acerta-pharma.com
Contacts for Patients and Clinical Trial Related Information
AstraZeneca Clinical Study Information Center
Call Center: 1-877-240-9479
All Adverse Events and Product Quality Complaints should be reported. Please consult the Adverse Events page to learn more.
Early Access
Early access to Acerta Pharma medicinal products
We recognize that there are circumstances where patients with serious or life-threatening diseases have exhausted all available therapeutic options and may not be eligible to enroll in one of our clinical trials. In such circumstances, individual patients may be eligible for early access to an Acerta medicinal product. Acerta Pharma reviews requests following principles aligned with AstraZeneca.